Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
DSwiss, Inc. is a biotech-nutraceutical company that supplies a comprehensive range of health and beauty products. Its market reach extends across Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. The company's product line includes specialized items like DSwiss coffee, targeting digestive well-being, and DSwiss kiwi, formulated to boost the immune system, improve skin tone, help manage blood pressure, and minimize the risk of heart disease and stroke. DSwiss Triple SC focuses on stem cell-related benefits. For skincare, DSwiss offers the DSwiss silk mask, designed for dry, damaged, and sensitive skin; the DSwiss coffee slimming scrub, a natural body exfoliant for removing impurities; the cooling DSwiss peppermint slimming gel; the DSwiss new age essence, which provides nutrients to moisturize, brighten, and refresh tired-looking skin; and the DSwiss enlighten essence cream, a light, nourishing formula. DSwiss also provides medical eyewear under the name DSwiss BioSpec. Its broader health offerings include Genmune-Pro, which strengthens the human immune system by enhancing digestive health; SkinEra, a solution for various skin conditions such as acne, pimples, atopic dermatitis, dry skin, and allergic rashes; SensiBath gel; and SuiSu hand purifiers, sanitizers, and air sanitizers. Specialized supplements include MasterLiv for liver support, MasterHeart for maintaining optimal heart health and smooth blood circulation, and WellG, which delivers essential nutrients for sugar metabolism and energy production. In addition to its product range, DSwiss, Inc. offers diagnostic and analytical equipment. This includes the DSwiss quantum magnetic analyzer, a device that interprets body energy fields to assess health status and offer recommendations, and an AI skin analyzer machine, a facial camera designed to collect skin image data. The company also provides turnkey private label manufacturing services and DNA microarray genotyping services. Furthermore, DSwiss supplies a variety of medical consumables, such as surgical gowns and gloves, 3-ply face masks, N95 masks, protective goggles, body infrared thermometers, disposable bedsheets, and stretcher covers. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overvalued on P/FCF.